Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 1, 2012, Pages 3-9

  Simba, Daudi O ^a,b   Kakoko, Deodatus ^a   Tomson, Goran ^b   Premji, Zul ^a   Petzold, Max ^b,c   Mahindi, Margarita ^d   Gustafsson, Lars L ^d  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adherence; Artemisinin based combination therapy; Blood lumefantrine analysis; Health systems; Rural community; Under five children

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BENFLUMETOL;

ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CHILD CARE; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; HOUSEHOLD; HUMAN; LIFE; MAJOR CLINICAL STUDY; MALARIA; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; RURAL AREA; TANZANIA;

ANALYSIS OF VARIANCE; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MEDICATION ADHERENCE; ODDS RATIO; RISK FACTORS; RURAL HEALTH; SOCIOECONOMIC FACTORS; TANZANIA;

EID: 83155181366     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.09.006     Document Type: Article

References (33)

1. Hinton R., Auwun A., Pongua G., Davis M. Caregivers' acceptance of using artesunate suppositories for treating childhood malaria in Papua New Guinea. Am J Trop Med Hyg 2007, 76:634-640.
2. Comoro C., Nsimba S.E., Warsame M., Tomson G. Local understanding, perceptions and reported practices of mothers/guardians and health workers on childhood malaria in a Tanzanian district-implications for malaria control. Acta Trop 2003, 87:305-313.
3. Makanga M., Premji Z., Falade C., Karbwang J., Mueller E., Andriano K., et al. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg 2006, 74:991-998.
4. Dondorp A., Yeung S., White L., Nguon C., Day N., Socheat D., et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 2010, 8:272-280.
5. Chinbuah A., Gyapong J., Pagnoni F., Wellington E., Gyapong M. Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health 2006, 11:1003-1016.
6. Fogg C., Bajunirwe F., Piola P., Biraro S., Checchi F., Kiguli J., et al. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg 2004, 71:525-530.
7. Beer N., Ali A., Rotllant G., Abass A., Omari R., Al-mafazy A., et al. Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania. Trop Med Int Health 2009, 14:766-774.
8. Kabanywanyi A., Lengeler C., Kasim P., King'eng'ena S., Schlienger R., Mulure N., et al. Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J 2010, 9:48.
9. Simba D, Warsame M, Kakoko D, Mrango Z, Tomson G, Premji Z, et al. Who gets prompt access to artemisinin-based combination therapy? A prospective community-based study in children from rural Kilosa, Tanzania. PLoS One 2010;5:pii: e12104.
10. Krause G., Sauerborn R. Comprehensive community effectiveness of health care. A study of malaria treatment in children and adults in rural Burkina Faso. Ann Trop Paediatr 2000, 20:273-282.
11. Nsungwa-Sabiiti J., Tomson G., Pariyo G., Ogwal-Okeng J., Peterson S. Community effectiveness of malaria treatment in Uganda-a long way to Abuja targets. Ann Trop Paediatr 2005, 25:89-98.
12. Agyepong I., Ansah E., Gyapong M., Adjei S., Barnish G., Evans D. Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Soc Sci Med 2002, 55:2215-2226.
13. Ansah E., Gyapong J., Agyepong I., Evans D. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health 2001, 6:496-504.
14. Gomes M., Faiz M., Gyapong J., Warsame M., Agbenyega T., Babiker A., et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet 2009, 373:557-566.
15. Nsungwa-Sabiiti J., Kallander K., Nsabagani X., Namusisi K., Pariyo G., Johansson A., et al. Local fever illness classifications: implications for home management of malaria strategies. Trop Med Int Health 2004, 9:1191-1199.
16. Simba D., Kakoko D., Warsame M., Premji Z., Gomes M., Tomson G., et al. Understanding caretakers' dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunate. Malar J 2010, 9:123.
17. de Savigny D., Mayombana C., Mwageni E., Masanja H., Minhaj A., Mkilindi Y., et al. Care-seeking patterns for fatal malaria in Tanzania. Malar J 2004, 3:27.
18. Eriksen J., Nsimba S., Minzi O., Sanga A., Petzoid M., Gustafsson L., et al. Adoption of the new antimalarial drug policy in Tanzania-a cross-sectional study in the community. Trop Med Int Health 2005, 10:1038-1046.
19. Ministry of Health and Social Welfare (MoHSW) National guidelines for malaria diagnosis and treatment 2006 2006, MoHSW, Dar es Salaam, Tanzania.
20. Ntale M., Ogwal-Okenga J., Mahindi M., Gustafsson L., Beck O. A field-adapted sampling and HPLC quantification method for lumefantrine and its desbutyl metabolite in whole blood spotted on filter paper. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 876:261-265.
21. National Bureau of Statistics (NBS Tanzania); Macro Tanzania Demographic and Health Survey 2004-05 2005, NBS and ORC Macro, Calverton, MD.
22. Yeung S., White N. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health 2005, 10:121-138.
23. Marsh K. Malaria disaster in Africa. Lancet 1998, 352:924-925.
24. Bell D., Wootton D., Mukaka M., Montgomery J. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J 2009, 8:204.
25. Price R., Uhlemann A., van Vugt M., Brockman A., Hutagalung R., Nair S., et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis 2006, 42:1570-1577.
26. Ezzet F., Van Vugt M., Nosten F., Looareesuwan S., White J. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother 2000, 44:697-704.
27. Ashley E., Stepniewska K., Lindegardh N., Annerberg A., Kham A., Brockman A., et al. How much fat is necessary to optimize lumefantrine oral bioavailability? Trop Med Int Health 2007, 12:195-200.
28. White N., van Vugt M., Ezzet F. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 1999, 37:105-125.
29. Obua C., Hellgren U., Ntale M., Gustafsson L., Ogwal-Okeng J., Gordi T., et al. Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen. Br J Clin Pharmacol 2008, 4:493-501.
30. Piola P., Fogg C., Bajumirwe F., Biraro S., Grandessa F., Ruzagira E., et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomized trial. Lancet 2005, 365:1467-1473.
31. Simba D., Warsame W., Kimbute O., Kakoko D., Petzold M., Tomson G., et al. Factors influencing adherence to referral advice following pre-referral treatment with artesunate suppositories in children in rural Tanzania. Trop Med Int Health 2009, 14:775-783.
32. White N. Antimalarial drug resistance. J Clin Invest 2004, 113:1084-1092.
33. Hildenwall H., Lindkvist J., Tumwine J., Bergqvist Y., Pariyo G., Tomson G., et al. Low validity of caretakers' reports on use of selected antimalarials and antibiotics in children with severe pneumonia at an urban hospital in Uganda. Trans R Soc Trop Med Hyg 2009, 103:95-101.